|
HY-P7765-10ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (75a.a)
|
|
|
|
|
HY-P7765-50ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (75a.a)
|
|
|
|
|
HY-P72786-10ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a)
|
|
|
|
|
HY-P72786-50ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a)
|
|
|
|
|
HY-P7259-10ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a, CHO)
|
|
|
|
|
HY-P7259-100ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a, CHO)
|
|
|
|
|
HY-P7259-2ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a, CHO)
|
|
|
|
|
HY-P7259-50ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a, CHO)
|
|
|
|
|
HY-110242-10mg
|
MedChemexpress LLC
|
Mps-BAY2a [CAS 1382477-96-4]
|
|
Cancer-programmed cell death
|
|
|
HY-110242-100mg
|
MedChemexpress LLC
|
Mps-BAY2a [CAS 1382477-96-4]
|
|
Cancer-programmed cell death
|
|
|
HY-110242-25mg
|
MedChemexpress LLC
|
Mps-BAY2a [CAS 1382477-96-4]
|
|
Cancer-programmed cell death
|
|
|
HY-110242-5mg
|
MedChemexpress LLC
|
Mps-BAY2a [CAS 1382477-96-4]
|
|
Cancer-programmed cell death
|
|
|
HY-110242-50mg
|
MedChemexpress LLC
|
Mps-BAY2a [CAS 1382477-96-4]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-10mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-100mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-25mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-5mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-50mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-1mL
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P70220-10ug
|
MedChemexpress LLC
|
MPZL1, Human (HEK293, His)
|
|
|
|
|
HY-P70220-50ug
|
MedChemexpress LLC
|
MPZL1, Human (HEK293, His)
|
|
|
|
|
HY-P700717-100ug
|
MedChemexpress LLC
|
MPZL2, Human (HEK293, hFc)
|
|
|
|
|
HY-P700717-20ug
|
MedChemexpress LLC
|
MPZL2, Human (HEK293, hFc)
|
|
|
|
|
HY-P700717-50ug
|
MedChemexpress LLC
|
MPZL2, Human (HEK293, hFc)
|
|
|
|
|
HY-138283-1mg
|
MedChemexpress LLC
|
MR837 [CAS 1210906-48-1]
|
|
Cancer-programmed cell death
|
|
